Posts

Is Launching an Oncology Drug a Harder Sell?

As anyone selling to Oncologists might tell you, being a specialty sales rep to this therapeutic area is probably one of the most complex pharma sales roles today. Why is that? More and more companies are adding oncology pipelines, more drugs…

Verix Helps Bayer Successfully Launch New Oncology Drugs

Bayer HealthCare Pharmaceutical is a large multinational company with 37,700 employees and net sales of €11B. In 2012 Bayer US Pharma was set to launch two new high profile oncology drugs. Managing drug launches is complicated, with incoming…

Reflections on Bayer’s 2014 Plan of Action Event

, , ,
Last week was a truly invigorating experience. Along with Doron Aspitz, Verix’s CEO and Yaron Makleff, Director of Services, I attended Bayer’s annual POA (Plan of Action) event at the Rosen Shingle Creek hotel in Orlando, FL. Bayer’s…